SGLT2阻害薬
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259905/.
1 2 Clar, Christine; Gill, James Alexander; Court, Rachel; Waugh, Norman (2012). “Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes”. BMJ Open 2 (5): e001007. doi:10.1136/bmjopen-2012-001007. PMC 3488745. PMID 23087012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488745/.
↑ Nauck, Michael (2014). “Update on developments with SGLT2 inhibitors in the management of type 2 diabetes”. Drug Design, Development and Therapy 8: 1335–80. doi:10.2147/DDDT.S50773. PMC 4166348. PMID 25246775. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166348/.
↑ Zheng, Sean L.; Roddick, Alistair J.; Aghar-Jaffar, Rochan; Shun-Shin, Matthew J.; Francis, Darrel; Oliver, Nick; Meeran, Karim (2018).